The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug-Eluting Bioabsorbable Stents Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Drug-Eluting Bioabsorbable Stents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drug-Eluting Bioabsorbable Stents market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Coronary Artery Diseases accounting for % of the Drug-Eluting Bioabsorbable Stents global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Serolimus and Paclitaxel Drug-Eluting Stents segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Drug-Eluting Bioabsorbable Stents include Medtronic, B.Braun Melsungen, Abbott Laboratories, Boston Scientific Corporation, and Biosensors International, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drug-Eluting Bioabsorbable Stents market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Serolimus and Paclitaxel Drug-Eluting Stents
Sirolimus Drug Eluting Stents
Market segment by Application can be divided into
Coronary Artery Diseases
Peripheral Artery Diseases
The key market players for global Drug-Eluting Bioabsorbable Stents market are listed below:
Medtronic
B.Braun Melsungen
Abbott Laboratories
Boston Scientific Corporation
Biosensors International
Terumo Corporation.
MicroPort Scientific Corporation
Alvimedica
Biotronik
Elixir Medical Corporation
Innovative Health Technologies
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug-Eluting Bioabsorbable Stents product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drug-Eluting Bioabsorbable Stents, with price, sales, revenue and global market share of Drug-Eluting Bioabsorbable Stents from 2019 to 2022.
Chapter 3, the Drug-Eluting Bioabsorbable Stents competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug-Eluting Bioabsorbable Stents breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Drug-Eluting Bioabsorbable Stents market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug-Eluting Bioabsorbable Stents.
Chapter 13, 14, and 15, to describe Drug-Eluting Bioabsorbable Stents sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Drug-Eluting Bioabsorbable Stents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drug-Eluting Bioabsorbable Stents market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Coronary Artery Diseases accounting for % of the Drug-Eluting Bioabsorbable Stents global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Serolimus and Paclitaxel Drug-Eluting Stents segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Drug-Eluting Bioabsorbable Stents include Medtronic, B.Braun Melsungen, Abbott Laboratories, Boston Scientific Corporation, and Biosensors International, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drug-Eluting Bioabsorbable Stents market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Serolimus and Paclitaxel Drug-Eluting Stents
Sirolimus Drug Eluting Stents
Market segment by Application can be divided into
Coronary Artery Diseases
Peripheral Artery Diseases
The key market players for global Drug-Eluting Bioabsorbable Stents market are listed below:
Medtronic
B.Braun Melsungen
Abbott Laboratories
Boston Scientific Corporation
Biosensors International
Terumo Corporation.
MicroPort Scientific Corporation
Alvimedica
Biotronik
Elixir Medical Corporation
Innovative Health Technologies
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug-Eluting Bioabsorbable Stents product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drug-Eluting Bioabsorbable Stents, with price, sales, revenue and global market share of Drug-Eluting Bioabsorbable Stents from 2019 to 2022.
Chapter 3, the Drug-Eluting Bioabsorbable Stents competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug-Eluting Bioabsorbable Stents breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Drug-Eluting Bioabsorbable Stents market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug-Eluting Bioabsorbable Stents.
Chapter 13, 14, and 15, to describe Drug-Eluting Bioabsorbable Stents sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Drug-Eluting Bioabsorbable Stents Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drug-Eluting Bioabsorbable Stents Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Serolimus and Paclitaxel Drug-Eluting Stents
1.2.3 Sirolimus Drug Eluting Stents
1.3 Market Analysis by Application
1.3.1 Overview: Global Drug-Eluting Bioabsorbable Stents Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Coronary Artery Diseases
1.3.3 Peripheral Artery Diseases
1.4 Global Drug-Eluting Bioabsorbable Stents Market Size & Forecast
1.4.1 Global Drug-Eluting Bioabsorbable Stents Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drug-Eluting Bioabsorbable Stents Sales in Volume (2017-2028)
1.4.3 Global Drug-Eluting Bioabsorbable Stents Price (2017-2028)
1.5 Global Drug-Eluting Bioabsorbable Stents Production Capacity Analysis
1.5.1 Global Drug-Eluting Bioabsorbable Stents Total Production Capacity (2017-2028)
1.5.2 Global Drug-Eluting Bioabsorbable Stents Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drug-Eluting Bioabsorbable Stents Market Drivers
1.6.2 Drug-Eluting Bioabsorbable Stents Market Restraints
1.6.3 Drug-Eluting Bioabsorbable Stents Trends Analysis
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Drug-Eluting Bioabsorbable Stents Product and Services
2.1.4 Medtronic Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 B.Braun Melsungen
2.2.1 B.Braun Melsungen Details
2.2.2 B.Braun Melsungen Major Business
2.2.3 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product and Services
2.2.4 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product and Services
2.3.4 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Boston Scientific Corporation
2.4.1 Boston Scientific Corporation Details
2.4.2 Boston Scientific Corporation Major Business
2.4.3 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product and Services
2.4.4 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Biosensors International
2.5.1 Biosensors International Details
2.5.2 Biosensors International Major Business
2.5.3 Biosensors International Drug-Eluting Bioabsorbable Stents Product and Services
2.5.4 Biosensors International Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Terumo Corporation.
2.6.1 Terumo Corporation. Details
2.6.2 Terumo Corporation. Major Business
2.6.3 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product and Services
2.6.4 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 MicroPort Scientific Corporation
2.7.1 MicroPort Scientific Corporation Details
2.7.2 MicroPort Scientific Corporation Major Business
2.7.3 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product and Services
2.7.4 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Alvimedica
2.8.1 Alvimedica Details
2.8.2 Alvimedica Major Business
2.8.3 Alvimedica Drug-Eluting Bioabsorbable Stents Product and Services
2.8.4 Alvimedica Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Biotronik
2.9.1 Biotronik Details
2.9.2 Biotronik Major Business
2.9.3 Biotronik Drug-Eluting Bioabsorbable Stents Product and Services
2.9.4 Biotronik Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Elixir Medical Corporation
2.10.1 Elixir Medical Corporation Details
2.10.2 Elixir Medical Corporation Major Business
2.10.3 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product and Services
2.10.4 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Innovative Health Technologies
2.11.1 Innovative Health Technologies Details
2.11.2 Innovative Health Technologies Major Business
2.11.3 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product and Services
2.11.4 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drug-Eluting Bioabsorbable Stents Breakdown Data by Manufacturer
3.1 Global Drug-Eluting Bioabsorbable Stents Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drug-Eluting Bioabsorbable Stents
3.4 Market Concentration Rate
3.4.1 Top 3 Drug-Eluting Bioabsorbable Stents Manufacturer Market Share in 2021
3.4.2 Top 6 Drug-Eluting Bioabsorbable Stents Manufacturer Market Share in 2021
3.5 Global Drug-Eluting Bioabsorbable Stents Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drug-Eluting Bioabsorbable Stents Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drug-Eluting Bioabsorbable Stents Market Size by Region
4.1.1 Global Drug-Eluting Bioabsorbable Stents Sales in Volume by Region (2017-2028)
4.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Region (2017-2028)
4.2 North America Drug-Eluting Bioabsorbable Stents Revenue (2017-2028)
4.3 Europe Drug-Eluting Bioabsorbable Stents Revenue (2017-2028)
4.4 Asia-Pacific Drug-Eluting Bioabsorbable Stents Revenue (2017-2028)
4.5 South America Drug-Eluting Bioabsorbable Stents Revenue (2017-2028)
4.6 Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Drug-Eluting Bioabsorbable Stents Sales in Volume by Type (2017-2028)
5.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2017-2028)
5.3 Global Drug-Eluting Bioabsorbable Stents Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Drug-Eluting Bioabsorbable Stents Sales in Volume by Application (2017-2028)
6.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Application (2017-2028)
6.3 Global Drug-Eluting Bioabsorbable Stents Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2028)
7.2 North America Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2028)
7.3 North America Drug-Eluting Bioabsorbable Stents Market Size by Country
7.3.1 North America Drug-Eluting Bioabsorbable Stents Sales in Volume by Country (2017-2028)
7.3.2 North America Drug-Eluting Bioabsorbable Stents Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2028)
8.2 Europe Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2028)
8.3 Europe Drug-Eluting Bioabsorbable Stents Market Size by Country
8.3.1 Europe Drug-Eluting Bioabsorbable Stents Sales in Volume by Country (2017-2028)
8.3.2 Europe Drug-Eluting Bioabsorbable Stents Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2028)
9.2 Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2028)
9.3 Asia-Pacific Drug-Eluting Bioabsorbable Stents Market Size by Region
9.3.1 Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drug-Eluting Bioabsorbable Stents Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2028)
10.2 South America Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2028)
10.3 South America Drug-Eluting Bioabsorbable Stents Market Size by Country
10.3.1 South America Drug-Eluting Bioabsorbable Stents Sales in Volume by Country (2017-2028)
10.3.2 South America Drug-Eluting Bioabsorbable Stents Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2028)
11.2 Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2028)
11.3 Middle East & Africa Drug-Eluting Bioabsorbable Stents Market Size by Country
11.3.1 Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drug-Eluting Bioabsorbable Stents Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Drug-Eluting Bioabsorbable Stents and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drug-Eluting Bioabsorbable Stents
12.3 Drug-Eluting Bioabsorbable Stents Production Process
12.4 Drug-Eluting Bioabsorbable Stents Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drug-Eluting Bioabsorbable Stents Typical Distributors
13.3 Drug-Eluting Bioabsorbable Stents Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Drug-Eluting Bioabsorbable Stents Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drug-Eluting Bioabsorbable Stents Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Medtronic Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic Major Business
Table 5. Medtronic Drug-Eluting Bioabsorbable Stents Product and Services
Table 6. Medtronic Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. B.Braun Melsungen Basic Information, Manufacturing Base and Competitors
Table 8. B.Braun Melsungen Major Business
Table 9. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product and Services
Table 10. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 12. Abbott Laboratories Major Business
Table 13. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product and Services
Table 14. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 16. Boston Scientific Corporation Major Business
Table 17. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product and Services
Table 18. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Biosensors International Basic Information, Manufacturing Base and Competitors
Table 20. Biosensors International Major Business
Table 21. Biosensors International Drug-Eluting Bioabsorbable Stents Product and Services
Table 22. Biosensors International Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Terumo Corporation. Basic Information, Manufacturing Base and Competitors
Table 24. Terumo Corporation. Major Business
Table 25. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product and Services
Table 26. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. MicroPort Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 28. MicroPort Scientific Corporation Major Business
Table 29. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product and Services
Table 30. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Alvimedica Basic Information, Manufacturing Base and Competitors
Table 32. Alvimedica Major Business
Table 33. Alvimedica Drug-Eluting Bioabsorbable Stents Product and Services
Table 34. Alvimedica Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Biotronik Basic Information, Manufacturing Base and Competitors
Table 36. Biotronik Major Business
Table 37. Biotronik Drug-Eluting Bioabsorbable Stents Product and Services
Table 38. Biotronik Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Elixir Medical Corporation Basic Information, Manufacturing Base and Competitors
Table 40. Elixir Medical Corporation Major Business
Table 41. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product and Services
Table 42. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Innovative Health Technologies Basic Information, Manufacturing Base and Competitors
Table 44. Innovative Health Technologies Major Business
Table 45. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product and Services
Table 46. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Drug-Eluting Bioabsorbable Stents Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 48. Global Drug-Eluting Bioabsorbable Stents Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Drug-Eluting Bioabsorbable Stents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Drug-Eluting Bioabsorbable Stents Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Drug-Eluting Bioabsorbable Stents Production Site of Key Manufacturer
Table 52. Drug-Eluting Bioabsorbable Stents New Entrant and Capacity Expansion Plans
Table 53. Drug-Eluting Bioabsorbable Stents Mergers & Acquisitions in the Past Five Years
Table 54. Global Drug-Eluting Bioabsorbable Stents Sales by Region (2017-2022) & (K Units)
Table 55. Global Drug-Eluting Bioabsorbable Stents Sales by Region (2023-2028) & (K Units)
Table 56. Global Drug-Eluting Bioabsorbable Stents Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Drug-Eluting Bioabsorbable Stents Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2022) & (K Units)
Table 59. Global Drug-Eluting Bioabsorbable Stents Sales by Type (2023-2028) & (K Units)
Table 60. Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Drug-Eluting Bioabsorbable Stents Price by Type (2017-2022) & (USD/Unit)
Table 63. Global Drug-Eluting Bioabsorbable Stents Price by Type (2023-2028) & (USD/Unit)
Table 64. Global Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2022) & (K Units)
Table 65. Global Drug-Eluting Bioabsorbable Stents Sales by Application (2023-2028) & (K Units)
Table 66. Global Drug-Eluting Bioabsorbable Stents Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Drug-Eluting Bioabsorbable Stents Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Drug-Eluting Bioabsorbable Stents Price by Application (2017-2022) & (USD/Unit)
Table 69. Global Drug-Eluting Bioabsorbable Stents Price by Application (2023-2028) & (USD/Unit)
Table 70. North America Drug-Eluting Bioabsorbable Stents Sales by Country (2017-2022) & (K Units)
Table 71. North America Drug-Eluting Bioabsorbable Stents Sales by Country (2023-2028) & (K Units)
Table 72. North America Drug-Eluting Bioabsorbable Stents Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Drug-Eluting Bioabsorbable Stents Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2022) & (K Units)
Table 75. North America Drug-Eluting Bioabsorbable Stents Sales by Type (2023-2028) & (K Units)
Table 76. North America Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2022) & (K Units)
Table 77. North America Drug-Eluting Bioabsorbable Stents Sales by Application (2023-2028) & (K Units)
Table 78. Europe Drug-Eluting Bioabsorbable Stents Sales by Country (2017-2022) & (K Units)
Table 79. Europe Drug-Eluting Bioabsorbable Stents Sales by Country (2023-2028) & (K Units)
Table 80. Europe Drug-Eluting Bioabsorbable Stents Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Drug-Eluting Bioabsorbable Stents Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2022) & (K Units)
Table 83. Europe Drug-Eluting Bioabsorbable Stents Sales by Type (2023-2028) & (K Units)
Table 84. Europe Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2022) & (K Units)
Table 85. Europe Drug-Eluting Bioabsorbable Stents Sales by Application (2023-2028) & (K Units)
Table 86. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Region (2017-2022) & (K Units)
Table 87. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Region (2023-2028) & (K Units)
Table 88. Asia-Pacific Drug-Eluting Bioabsorbable Stents Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Drug-Eluting Bioabsorbable Stents Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2022) & (K Units)
Table 91. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Type (2023-2028) & (K Units)
Table 92. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2022) & (K Units)
Table 93. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Application (2023-2028) & (K Units)
Table 94. South America Drug-Eluting Bioabsorbable Stents Sales by Country (2017-2022) & (K Units)
Table 95. South America Drug-Eluting Bioabsorbable Stents Sales by Country (2023-2028) & (K Units)
Table 96. South America Drug-Eluting Bioabsorbable Stents Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Drug-Eluting Bioabsorbable Stents Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2022) & (K Units)
Table 99. South America Drug-Eluting Bioabsorbable Stents Sales by Type (2023-2028) & (K Units)
Table 100. South America Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2022) & (K Units)
Table 101. South America Drug-Eluting Bioabsorbable Stents Sales by Application (2023-2028) & (K Units)
Table 102. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Region (2017-2022) & (K Units)
Table 103. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Region (2023-2028) & (K Units)
Table 104. Middle East & Africa Drug-Eluting Bioabsorbable Stents Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Drug-Eluting Bioabsorbable Stents Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2022) & (K Units)
Table 107. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Type (2023-2028) & (K Units)
Table 108. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2022) & (K Units)
Table 109. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Application (2023-2028) & (K Units)
Table 110. Drug-Eluting Bioabsorbable Stents Raw Material
Table 111. Key Manufacturers of Drug-Eluting Bioabsorbable Stents Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Drug-Eluting Bioabsorbable Stents Typical Distributors
Table 115. Drug-Eluting Bioabsorbable Stents Typical Customers
List of Figures
Figure 1. Drug-Eluting Bioabsorbable Stents Picture
Figure 2. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Type in 2021
Figure 3. Serolimus and Paclitaxel Drug-Eluting Stents
Figure 4. Sirolimus Drug Eluting Stents
Figure 5. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Application in 2021
Figure 6. Coronary Artery Diseases
Figure 7. Peripheral Artery Diseases
Figure 8. Global Drug-Eluting Bioabsorbable Stents Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Drug-Eluting Bioabsorbable Stents Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Drug-Eluting Bioabsorbable Stents Sales (2017-2028) & (K Units)
Figure 11. Global Drug-Eluting Bioabsorbable Stents Price (2017-2028) & (USD/Unit)
Figure 12. Global Drug-Eluting Bioabsorbable Stents Production Capacity (2017-2028) & (K Units)
Figure 13. Global Drug-Eluting Bioabsorbable Stents Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Drug-Eluting Bioabsorbable Stents Market Drivers
Figure 15. Drug-Eluting Bioabsorbable Stents Market Restraints
Figure 16. Drug-Eluting Bioabsorbable Stents Market Trends
Figure 17. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Manufacturer in 2021
Figure 18. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Manufacturer in 2021
Figure 19. Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Drug-Eluting Bioabsorbable Stents Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Drug-Eluting Bioabsorbable Stents Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2017-2028)
Figure 23. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2017-2028)
Figure 24. North America Drug-Eluting Bioabsorbable Stents Revenue (2017-2028) & (USD Million)
Figure 25. Europe Drug-Eluting Bioabsorbable Stents Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Drug-Eluting Bioabsorbable Stents Revenue (2017-2028) & (USD Million)
Figure 27. South America Drug-Eluting Bioabsorbable Stents Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Drug-Eluting Bioabsorbable Stents Revenue (2017-2028) & (USD Million)
Figure 29. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2017-2028)
Figure 30. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Type (2017-2028)
Figure 31. Global Drug-Eluting Bioabsorbable Stents Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2017-2028)
Figure 33. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Application (2017-2028)
Figure 34. Global Drug-Eluting Bioabsorbable Stents Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2017-2028)
Figure 36. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2017-2028)
Figure 37. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2017-2028)
Figure 38. North America Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2017-2028)
Figure 39. United States Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2017-2028)
Figure 43. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2017-2028)
Figure 44. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2017-2028)
Figure 45. Europe Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2017-2028)
Figure 46. Germany Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2017-2028)
Figure 55. China Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2017-2028)
Figure 62. South America Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2017-2028)
Figure 63. South America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2017-2028)
Figure 64. South America Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Drug-Eluting Bioabsorbable Stents in 2021
Figure 76. Manufacturing Process Analysis of Drug-Eluting Bioabsorbable Stents
Figure 77. Drug-Eluting Bioabsorbable Stents Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
